Hammack 2002.
Methods | Double‐blind, placebo‐controlled, cross‐over, RCT |
Participants | Patients who had received CDDP (cisplatin) chemotherapy, and have had painful paresthaesiae for at least 1 month attributed to CDDP neuropathy. n = 51 |
Interventions | Nortriptyline 100 mg Placebo |
Outcomes | Pain Sleep Quality of life AEs |
Notes | Unable to ascertain pain duration ‐ inclusion criteria only says at least 1 month |